WOOJUNG BIO Inc (215380) — Capital Reinvestment Ratio
WOOJUNG BIO Inc (215380) has a Capital Reinvestment Ratio of 0.12x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩1.59 Billion) in capital expenditures (₩191.51 Million). Check 215380 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
WOOJUNG BIO Inc Capital Reinvestment Ratio (2019–2022)
This chart tracks WOOJUNG BIO Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see WOOJUNG BIO Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for WOOJUNG BIO Inc (2019–2022)
Year-by-year Capital Reinvestment Ratio for WOOJUNG BIO Inc from 2019 to 2022. See WOOJUNG BIO Inc (215380) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 4.56x | ₩2.50 Billion | ₩11.42 Billion | ▼ -78.5% |
| 2021 | 21.23x | ₩1.73 Billion | ₩36.68 Billion | ▲ +105.0% |
| 2019 | 10.36x | ₩208.72 Million | ₩2.16 Billion | — |